Nordicus Partners Corporation

US$3.21As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NORDHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (13.53%)
Div yield —
ROE (8.19%)
Biotechnology
Beta (5Y) (0.63)
PE TTM —
TSR TTM (35.70%)
Mkt cap US$62.70M
ROIC (4.33%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.76
16.90%
(68.14%)
Hold 2|4|4|11|10
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.07
0.08
0.07
0.07
9.30%
26.26%
18.23%
4.58%
Revenue$M
3.022
3.160
3.295
3.490
9.17%
9.82%
10.18%
14.25%
Peers (US$62.70M)
Cap (US$)
PE
61.95M
—
61.70M
0.569x
Capital
TTM
5Y
10Y
Leveragex
0.337
0.580
0.576
EBIT/Intx
0.358
0.241
0.234
Own earn%
(44.04)
(261.88)
(230.41)
Sh yield%
31.48
43.49
41.02
Owners
Insiders/Inst%
14.96
73.23
Short interest%
3.84
SBC / revenue%
2.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
20–28
$1 testx
0.3
Incr. ROIC%
5